Literature DB >> 19479383

Treatment options in metastatic squamous cell carcinoma of the anal canal.

Cathy Eng1, Priyanka Pathak.   

Abstract

Squamous cell carcinoma of the anal canal is a rare malignancy that is often cured with the combined modality therapy of chemoradiation. Yet, a minority of patients will develop distant metastatic disease, an area of oncology in which a universally accepted approach has not been determined. Consideration of platinum-based systemic chemotherapy is commonly provided for palliation with the optimal duration of therapy being largely unknown; the role of biologics and/or surgical resection of metastatic disease are anecdotal. Patients with no contraindications to systemic chemotherapy should be treated aggressively with consideration of multidisciplinary management if appropriate. Here, we present a summary of the existing literature in the treatment of metastatic anal carcinoma in the hopes of providing insight and potential treatment alternatives for the practicing physician.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19479383     DOI: 10.1007/s11864-009-0103-7

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  22 in total

1.  Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal.

Authors:  J A Ajani; C H Carrasco; D E Jackson; S Wallace
Journal:  Am J Med       Date:  1989-08       Impact factor: 4.965

2.  Evidence of clinical activity for cetuximab combined with irinotecan in a patient with refractory anal canal squamous-cell carcinoma: report of a case.

Authors:  Lan K Phan; Paulo M Hoff
Journal:  Dis Colon Rectum       Date:  2007-03       Impact factor: 4.585

3.  Activity of paclitaxel in metastatic squamous anal carcinoma.

Authors:  Thierry Alcindor
Journal:  Int J Colorectal Dis       Date:  2008-03-12       Impact factor: 2.571

Review 4.  Anal cancer: current and future methodology.

Authors:  Cathy Eng
Journal:  Cancer Invest       Date:  2006 Aug-Sep       Impact factor: 2.176

5.  Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.

Authors: 
Journal:  Lancet       Date:  1996-10-19       Impact factor: 79.321

6.  Chemotherapy and radiation therapy for anal carcinoma. Survival and late morbidity.

Authors:  G Tanum; K Tveit; K O Karlsen; M Hauer-Jensen
Journal:  Cancer       Date:  1991-05-15       Impact factor: 6.860

7.  Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas: results of a Phase II trial.

Authors:  J D Hainsworth; H A Burris; A A Meluch; M N Baker; L H Morrissey; F A Greco
Journal:  Cancer       Date:  2001-08-01       Impact factor: 6.860

Review 8.  Combined multimodal approach to the treatment of metastatic anal carcinoma: report of a case and review of the literature.

Authors:  Margarita Tokar; Dmitri Bobilev; Svetlana Zalmanov; David B Geffen; Shlomo Walfisch
Journal:  Onkologie       Date:  2006-02

9.  Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis.

Authors:  Timothy M Pawlik; Ana Luiza Gleisner; Todd W Bauer; Reid B Adams; Srinevas K Reddy; Bryan M Clary; Robert C Martin; Charles R Scoggins; Kenneth K Tanabe; James S Michaelson; David A Kooby; Charles A Staley; Richard D Schulick; Jean-Nicolas Vauthey; Eddie K Abdalla; Steven A Curley; Michael A Choti; Dominque Elias
Journal:  Ann Surg Oncol       Date:  2007-06-06       Impact factor: 5.344

10.  Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy.

Authors:  F Di Fiore; F Blanchard; F Charbonnier; F Le Pessot; A Lamy; M P Galais; L Bastit; A Killian; R Sesboüé; J J Tuech; A M Queuniet; B Paillot; J C Sabourin; F Michot; P Michel; T Frebourg
Journal:  Br J Cancer       Date:  2007-03-20       Impact factor: 7.640

View more
  5 in total

1.  Anal cancer with cerebral metastasis: a case report.

Authors:  Anand I Rughani; Chih Lin; Bruce I Tranmer; James T Wilson
Journal:  J Neurooncol       Date:  2010-05-04       Impact factor: 4.130

2.  Stage IV anal canal squamous cell carcinoma with long-term survival: a case report.

Authors:  Katsuji Sawai; Takanori Goi; Noriyuki Tagai; Hidetaka Kurebayashi; Mitsuhiro Morikawa; Kenji Koneri; Masato Tamaki; Makoto Murakami; Yasuo Hirono; Hiroyuki Maeda
Journal:  Surg Case Rep       Date:  2022-06-20

Review 3.  Optimal treatment strategies for anal cancer.

Authors:  Shahab Ahmed; Cathy Eng
Journal:  Curr Treat Options Oncol       Date:  2014-09

4.  The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal.

Authors:  Cathy Eng; George J Chang; Y Nancy You; Prajnan Das; Miguel Rodriguez-Bigas; Yan Xing; Jean-Nicolas Vauthey; Jane E Rogers; Aki Ohinata; Priyanka Pathak; Salil Sethi; Jonathan K Phillips; Christopher H Crane; Robert A Wolff
Journal:  Oncotarget       Date:  2014-11-30

5.  Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapy.

Authors:  Ninoska N Silva; Cathy Eng
Journal:  J Adv Pract Oncol       Date:  2012-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.